Tobradex Ointment
FDA Label NDC 0078-0876

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Novartis Pharmaceuticals Corporation for the product Tobradex (NDC 0078-0876). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Principal Display Panel

NDC 0078-0876-01

TobraDex®

(tobramycin and dexamethasone ophthalmic ointment)

Sterile 3.5 g Net Wt.

Rx Only

NOVARTIS

Principal Display Panel Ndc 0078-0876-01 Tobradex® (tobramycin And Dexamethasone Ophthalmic Ointment) Sterile 3.5 G Net Wt. Rx Only Novartis (Carton)

Principal Display Panel Ndc 0078-0876-01 Tobradex® (tobramycin And Dexamethasone Ophthalmic Ointment) Sterile 3.5 G Net Wt. Rx Only Novartis (Carton)

* Please review the disclaimer below.